Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Precise Evaluation Criteria for Histological Regression of NASH-related Liver Fibrosis

NCT06364462 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT06364462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06364462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Precise Evaluation Criteria for Histological Regression of NASH-related Liver Fibrosis
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
June 15, 2024
Completion date
April 1, 2027
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver fibrosis, nash